These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31607242)

  • 21. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
    BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.
    Lee YJ; Je NK
    Eur J Clin Pharmacol; 2023 Aug; 79(8):1107-1116. PubMed ID: 37310478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
    Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
    Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis.
    Hou X; Cen K; Cui Y; Zhang Y; Feng X
    Eur J Clin Pharmacol; 2023 Jan; 79(1):63-70. PubMed ID: 36342528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol for secondary stroke prevention: systematic review and meta-analysis.
    Tan CH; Wu AG; Sia CH; Leow AS; Chan BP; Sharma VK; Yeo LL; Tan BY
    Stroke Vasc Neurol; 2021 Sep; 6(3):410-423. PubMed ID: 33542092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
    Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.
    Albay CEQ; Leyson FGD; Cheng FC
    BMC Neurol; 2020 Jun; 20(1):224. PubMed ID: 32493229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.
    Uchiyama S; Toyoda K; Okamura S; Omae K; Hoshino H; Kimura K; Kitagawa K; Minematsu K; Yamaguchi T
    Int J Stroke; 2023 Apr; 18(4):426-432. PubMed ID: 35762581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
    Ding L; Peng B
    Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.
    Dinicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH; Bangalore S; Messerli FH
    Am J Cardiol; 2013 Oct; 112(8):1230-4. PubMed ID: 23827403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis.
    Zitikyte G; Roy DC; Dhaliwal S; Lun R; Hutton B; Shorr R; Dowlatshahi D
    PLoS One; 2021; 16(4):e0250553. PubMed ID: 33909676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
    Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
    Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.
    Tan L; Margaret B; Zhang JH; Hu R; Yin Y; Cao L; Feng H; Zhang Y
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):930-8. PubMed ID: 25804574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
    Toyoda K; Omae K; Hoshino H; Uchiyama S; Kimura K; Miwa K; Minematsu K; Yamaguchi K; Suda Y; Toru S; Kitagawa K; Ihara M; Koga M; Yamaguchi T;
    Neurology; 2022 Mar; 98(10):e983-e992. PubMed ID: 35074890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack.
    Rahman H; Khan SU; Nasir F; Hammad T; Meyer MA; Kaluski E
    Stroke; 2019 Apr; 50(4):947-953. PubMed ID: 30852971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.